StratifiCare Company

StratifiCare is a medical company that focuses on the development and manufacturing of in vitro diagnostic medical devices it provides solutions for personalized medicine. StratifiCare features a panel of biomarkers which are able to determine the progress of dengue fever. The company was founded on July 13, 2015, and headquartered in Singapore.
Technology: Biomarkers
Industry: Biotechnology, Health Care, Hospital, Information Technology, Manufacturing
Headquarters: Singapore
Founded Date: 7-13
Employees Number: 43840
Funding Status: Seed
Total Funding: 1-2
Estimated Revenue: $1M to $10M
Last Funding Date: 43708
Last Funding Type: Seed

Visit Website
general@stratificare.com
https://twitter.com/StratifiCare
Register and Claim Ownership